Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Prepaid Assets (2022 - 2025)

Atara Biotherapeutics' Prepaid Assets history spans 4 years, with the latest figure at $2.5 million for Q4 2025.

  • For Q4 2025, Prepaid Assets fell 75.51% year-over-year to $2.5 million; the TTM value through Dec 2025 reached $2.5 million, down 75.51%, while the annual FY2025 figure was $2.5 million, 75.51% down from the prior year.
  • Prepaid Assets reached $2.5 million in Q4 2025 per ATRA's latest filing, down from $2.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $16.0 million in Q3 2022 to a low of $2.4 million in Q2 2025.
  • Average Prepaid Assets over 4 years is $8.5 million, with a median of $9.3 million recorded in 2023.
  • Peak YoY movement for Prepaid Assets: skyrocketed 63.57% in 2024, then crashed 75.51% in 2025.
  • A 4-year view of Prepaid Assets shows it stood at $10.3 million in 2022, then crashed by 40.01% to $6.2 million in 2023, then skyrocketed by 63.57% to $10.1 million in 2024, then plummeted by 75.51% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for ATRA's Prepaid Assets are $2.5 million (Q4 2025), $2.8 million (Q3 2025), and $2.4 million (Q2 2025).